[Dystrophic and non-dystrophic myotonias]

Area of Science:

• Neurology
• Genetics
• Molecular Biology

Background:

• Myotonic syndromes are rare neuromuscular diseases defined by myotonia, stemming from genetic defects in muscle ion channels.
• These channel dysfunctions cause muscle membrane hyperexcitability, leading to the hallmark symptom of myotonia.
• Known forms include dystrophic myotonic dystrophies (DM1, DM2) and non-dystrophic types, each with distinct genetic causes and clinical features.

Purpose of the Study:

• To provide an updated overview of the clinical, diagnostic, and therapeutic aspects of myotonic syndromes.
• To assist general neurologists in achieving earlier diagnosis and improved patient management.
• To clarify the differential diagnosis challenges inherent in myotonic syndrome identification.

Main Methods:

• Review of current literature on myotonic syndromes.
• Analysis of clinical presentations, genetic underpinnings, and diagnostic criteria.
• Synthesis of therapeutic strategies and management guidelines.

Main Results:

• Myotonic syndromes present with myotonia, muscle weakness, and potential multisystemic involvement (cataracts, diabetes, cardiac issues).
• Dystrophic forms (DM1, DM2) and non-dystrophic forms (affecting chloride or sodium channels) have distinct genetic bases and clinical spectra.
• Differential diagnosis is complex, often resulting in diagnostic delays.

Conclusions:

• Earlier and accurate diagnosis of myotonic syndromes is crucial for effective management.
• Understanding the genetic basis and clinical variability is key to differentiating between types.
• This review serves as a guide for neurologists to navigate the complexities of myotonic syndromes.